Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
38.11
+0.15 (0.40%)
Aug 31, 2026, 4:00 PM EDT - Market closed
Astrana Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,950 | 1,244 | 1,549 | 1,706 | 1,348 | 3,279 | |
Market Cap Growth | 11.47% | -19.65% | -9.23% | 26.59% | -58.90% | 387.82% |
Enterprise Value | 2,529 | 1,647 | 1,477 | 1,687 | 1,396 | 3,242 |
Last Close Price | 38.11 | 24.81 | 31.53 | 38.30 | 29.59 | 73.48 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 46.48 | 55.34 | 35.89 | 28.10 | 29.84 | 47.57 |
Forward PE | 22.93 | 29.95 | 25.02 | 30.62 | 65.76 | 63.35 |
PS Ratio | 0.51 | 0.39 | 0.76 | 1.23 | 1.18 | 4.24 |
PB Ratio | 2.26 | 2.23 | 3.01 | 4.15 | 2.41 | 6.42 |
P/TBV Ratio | - | - | 8.84 | 6.47 | 6.85 | 27.57 |
P/FCF Ratio | 20.66 | 11.91 | 35.07 | 42.98 | 22.77 | 64.15 |
P/OCF Ratio | 18.08 | 10.86 | 29.67 | 25.01 | 16.41 | 46.62 |
PEG Ratio | - | 0.89 | 1.36 | 2.14 | 1.49 | 2.50 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.66 | 0.52 | 0.73 | 1.22 | 1.22 | 4.19 |
EV/EBITDA Ratio | 14.46 | 11.45 | 12.59 | 16.48 | 11.46 | 28.03 |
EV/EBIT Ratio | 22.60 | 16.79 | 16.53 | 19.93 | 13.39 | 33.03 |
EV/FCF Ratio | 26.79 | 15.77 | 33.44 | 42.49 | 23.59 | 63.44 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.64 | 1.93 | 0.92 | 0.78 | 0.41 | 0.40 |
Debt / EBITDA Ratio | 5.09 | 6.79 | 3.59 | 2.92 | 1.79 | 1.67 |
Debt / FCF Ratio | 10.38 | 10.32 | 10.66 | 8.09 | 3.88 | 3.95 |
Net Debt / Equity Ratio | 0.97 | 1.16 | 0.35 | 0.06 | -0.11 | -0.16 |
Net Debt / EBITDA Ratio | 3.31 | 4.51 | 1.53 | 0.24 | -0.53 | -0.73 |
Net Debt / FCF Ratio | 6.13 | 6.21 | 4.07 | 0.63 | -1.08 | -1.65 |
Asset Turnover | 2.06 | 1.78 | 1.78 | 1.46 | 1.25 | 0.92 |
Quick Ratio | 1.19 | 1.35 | 1.68 | 2.03 | 2.76 | 3.33 |
Current Ratio | 1.23 | 1.40 | 1.75 | 2.11 | 2.88 | 3.53 |
Return on Equity (ROE) | 6.90% | 4.49% | 10.80% | 11.94% | 8.56% | 9.64% |
Return on Assets (ROA) | 3.75% | 3.43% | 4.88% | 5.57% | 7.11% | 7.28% |
Return on Invested Capital (ROIC) | 6.24% | 6.28% | 9.77% | 11.72% | 11.96% | 13.36% |
Return on Capital Employed (ROCE) | 7.30% | 6.10% | 9.00% | 11.80% | 12.80% | 13.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.08% | 1.81% | 2.79% | 3.56% | 3.35% | 2.10% |
FCF Yield | 4.84% | 8.40% | 2.85% | 2.33% | 4.39% | 1.56% |
Payout Ratio | - | 35.07% | - | 102.24% | 31.06% | 45.11% |
Buyback Yield / Dilution | -1.73% | -2.91% | -2.20% | -2.94% | -0.44% | -21.24% |